Viewing Study NCT02202135

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:44 PM
Ignite Modification Date: 2026-02-21 @ 6:24 AM
Study NCT ID: NCT02202135
Status: TERMINATED
Last Update Posted: 2017-09-06
First Post: 2014-07-25
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections.
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Complicated Skin and Soft Tissue Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None complicated skin and soft tissue infections (cSSTI) View
None skin infection View
None ceftaroline View
None wound infection View
None cellulitis View
None burn infection View
None bacterial infection View
None vancomycin View